Discover and read the best of Twitter Threads about #SIUJ
Most recents (4)
In last month’s issue of #SIUJ, @JessicaDeLong23 and @RamonVirasoro discuss the development of a GURS fellowship and training program in the Caribbean bit.ly/3tliRIb #OpenAccess #urology #urosome
(1/n)
(1/n)
With over 5 billion people lacking access to adequate surgical and anesthesia care across the globe, the global health community is focusing on reducing these health inequalities by improving access and overall outcomes.
(2/n)
(2/n)
During annual mission trips to Dominican Republic (DR), the authors recognized a need for more Urological Reconstructive Surgery trained physicians within the community. This need inspired the creation of a GURS in the DR.
(3/n)
(3/n)
In this #SIUJ editorial, @pcvblack discussed gender disparity in urology. Why is this a priority for @SIU_Journal and what barriers remain in place?
Read full article: siuj.org/index.php/siuj…
#OpenAccess
(1/n)
Read full article: siuj.org/index.php/siuj…
#OpenAccess
(1/n)
Gender disparity is a big problem that deserves a lot more attention within the urological community. The ultimate goal of gender equality is to develop a diverse urologic workforce that provides optimal patient care. (2/n)
We need to attract more women into training and more female urologists into leadership roles. Providing role models and mentorship for female medical students considering their career options is critical for enhancing female representation in urology. (3/n)
@LiangGQu, Vaisnavi Thirugnanasundralingam, @damien_bolton, @UroOncMD & @lawrentschuk reviewed the role of tissue-based immunohistochemical markers for diagnosis and classification of #RCC in this 1st edition of #SIUJ!
#OpenAccess #UroSoMe
siuj.org/index.php/siuj…
1/n
#OpenAccess #UroSoMe
siuj.org/index.php/siuj…
1/n
In the first issue of #SIUJ, @AnkeetShahMD @DominicGrimberg @BrantInman discussed the classification of molecular biomarkers. #OpenAccess siuj.org/index.php/siuj… (1/n)
A “biomarker” is any measurable characteristic that indicates the presence or absence of disease or the biological response to a stimulus, typically an exposure or intervention. (2/n)
The FDA-NIH Biomarker Working Group has produced a document called Biomarkers, EndpointS and other Tools (BEST), which defines 7 categories of biomarkers according to their clinical usage. (3/n)
